Evidence map›Paper›PMID 39717212›Full record

ArticleRadiology case reports2025

Behçet's disease and factor V Leiden: A thrombogenic synergy causing budd-chiari syndrome.

Ameer Awashra, Zaid Sawaftah, Salsabeel Bishawi, Aseel Eid, Aya Milhem, Dawoud Hamdan, Ali Bani Odah, Ahmad Sawafta, Jehad Khamaysa, Yazan Ghannam and 1 more

Abstract readCase Reports
In one paragraph

Article in Radiology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Ameer AwashraDepartment of Medicine, An Najah National University, Nablus, Palestine.
Zaid SawaftahDepartment of Medicine, An Najah National University, Nablus, Palestine.
Salsabeel BishawiDepartment of Medicine, An Najah National University, Nablus, Palestine.
Aseel EidDepartment of Medicine, An Najah National University, Nablus, Palestine.
Aya MilhemDepartment of Medicine, An Najah National University, Nablus, Palestine.
Dawoud HamdanDepartment of Medicine, An Najah National University, Nablus, Palestine.
Ali Bani OdahDepartment of Medicine, An Najah National University, Nablus, Palestine.
Ahmad SawaftaDepartment of Medicine, An Najah National University, Nablus, Palestine.
Jehad KhamaysaDepartment of Radiology, Tubas Turkish Governmental Hospital, Tubas, Palestine.
Yazan GhannamDepartment of Internal Medicine, Tubas Turkish Governmental Hospital, Tubas, Palestine.
Hadi RabeeDepartment of Internal Medicine, An Najah National University Hospital, Nablus, Palestine.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Behçet's Disease (BD) is a multisystem inflammatory disorder that can lead to severe vascular complications, including Budd-Chiari Syndrome (BCS), a rare but life-threatening condition characterized by hepatic vein obstruction. The co-occurrence of BD and inherited thrombophilia, such as Factor V Leiden mutation, significantly increases the risk of thrombosis, complicating the clinical management of affected individuals. In this case, a 16-year-old female initially presented with nonspecific symptoms of generalized fatigue and bone pain, which later progressed to abdominal distension and significant hepatosplenomegaly. Imaging and further diagnostic evaluation confirmed BCS as the initial manifestation of BD, a rare but severe complication. Genetic testing revealed a heterozygous mutation for Factor V Leiden and the presence of the HLA-B51 allele, highlighting a thrombogenic synergy between BD and inherited thrombophilia. Aggressive anticoagulation therapy was initiated, resulting in partial recanalization of the hepatic veins and stabilization of the patient's condition. This case emphasizes the need for early consideration of BCS in BD patients, especially in those with concurrent prothrombotic disorders, as timely intervention is crucial for improving clinical outcomes. The interplay of autoimmune and genetic factors in this case provides valuable insights into the complex pathophysiology and management of BCS associated with BD.

Indexed as

Behçet's diseaseBudd chiari syndromeThrombosis

Identifiers

PMID39717212
PMCPMC11665683

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.